Centers for Disease Control and Prevention: protecting the private good?

After revelations that the CDC is receiving some funding from industry, Jeanne Lenzer investigates how it might have affected the organisation’s decisions

Saved in:

Bibliographic Details
Published in	BMJ (Online) Vol. 350; no. may15 3; p. h2362
Main Author	Lenzer, Jeanne
Format	Journal Article
Language	English
Published	England British Medical Journal Publishing Group 15.05.2015 BMJ Publishing Group LTD
Subjects	Advisors Centers for Disease Control and Prevention (U.S.) - economics Centers for Disease Control and Prevention (U.S.) - ethics COMPETING INTERESTS Conflict of Interest - economics Conflicts of interest Disclosure Disease control Disease prevention Donations Drugs Financial Support - ethics Funding Gifts Hepatitis C Industry - economics Infectious diseases Influenza Laboratories Manufacturers Pharmaceutical industry Public health Tobacco United States United States United States > US Massachusetts
Online Access	Get full text
ISSN	0959-8138 1756-1833 1756-1833
DOI	10.1136/bmj.h2362

Cover

More Information
Summary:	After revelations that the CDC is receiving some funding from industry, Jeanne Lenzer investigates how it might have affected the organisation’s decisions
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ISSN:	0959-8138 1756-1833 1756-1833
DOI:	10.1136/bmj.h2362